Upcoming Health Conferences in Boston, United States

Now more than ever, exosome and EV therapies are on the verge of groundbreaking clinical and commercial breakthroughs. With recent milestones like ...

As CRISPR-based therapies become ever complex, drug developers urgently need to innovate the analytical tools available to effectively characterize...

The commercial success of cell therapies is continuing to grow! With a recent TIL approval, a shift to earlier line CAR-T treatment, and further ap...

Madrigal's blockbuster drug gaining FDA approval this March has opened the doors to a wave of therapeutics from Eli Lilly, Boehringer Ingelheim, As...

The clinical potential of radiopharmaceuticals is huge and with continued multi-billion-dollar investments from pharmaceutical giants such as Novar...

Uniting Large Pharma, Innovative Biotech and Leading Academics to Defeat the Holy Grail Target in Precision Oncology With tumor and patient hete...

With Karuna's schizophrenia program coined as the most anticipated drug launch of 2024, and 2023 bringing brand new regulatory guidance, surging in...

The drive for at-home patient care, high-volume injectables and evolving regulations is driving the injectables landscape. Recent innovations from ...

With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking ...

Despite toxicity concerns for CD47 targets in 2023, the macrophage therapies space remains determined to drive revolutionary treatments for oncolog...

Antibody-drug conjugates (ADCs) have emerged as a rapidly evolving, highly promising class of oncology drugs, with 12 approvals and many more in de...

Are you listening to your patient community? It's not enough. Standing in the shadows and harvesting anecdotal insights won't build connections, cr...